Cochlear Ltd (ASX: COH) is one of the world’s leading medical businesses. Cochlear designs, manufactures and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant. Graeme Clark invented the first device in 1982, allowing first-user Graham Carrick to hear for the first time for 17 years. Some of the most recent modifications allow users to play sound from their phone directly into their implant.
The S&P/ASX 200 (INDEXASX: XJO) is expected to edge lower this morning. Westpac Banking (ASX:WBC), BHP Group (ASX:BHP) and Cochlear (ASX:COH) are in the news.
The Cochlear Limited (ASX:COH) share price is soaring today in response to the company’s full-year FY20 results. Here’s my take on the report.
The Cochlear Limited (ASX: COH) share price will be on watch today after the company released its full-year financial report. Here are the key points.
Cochlear (ASX:COH) has revealed an update about the lawsuit it’s facing in the US. It has announced a US$75 million settlement.
Cochlear (ASX:COH) shares are up 3% after making a positive announcement regarding FDA approval.
The Cochlear (ASX:COH) share price is on watch this morning after the hearing aid business announced a trading update.
The S&P/ASX 200 (ASX: XJO) was trading down 0.83% at lunchtime today.
Cochlear, Webjet, Flight Centre… for the most part, it seems ASX investors have welcomed the latest patch of capital raisings.
So far companies like QBE Insurance Group Ltd (ASX: QBE), Webjet Limited (ASX: WEB), Flight Centre Travel Ltd (ASX: FLT) and Cochlear (ASX: COH).
